Citations for
1COMT
Endothelial dysfunction in gestational hypertension induced by catechol-O-methyltransferase inhibition.
Hernandez M, Hernandez I, Rodriguez F, Pertegal M, Bonacasa B, Salom MG, Quesada T, Fenoy FJ.
Exp Physiol 98(3):856-66. doi: 10.1113/expphysiol.2012.067389. Epub 2012 Oct 26. 2013
2BDNF, COMT
Interaction of BDNF and COMT polymorphisms on paired-associative stimulation-induced cortical plasticity.
Witte AV, Kürten J, Jansen S, Schirmacher A, Brand E, Sommer J, Flöel A.
J Neurosci 32(13):4553-61. doi: 10.1523/JNEUROSCI.6010-11.2012. 2012
3COMT
Serotonin-induced hypersensitivity via inhibition of catechol O-methyltransferase activity.
Tsao D, Wieskopf JS, Rashid N, Sorge RE, Redler RL, Segall SK, Mogil JS, Maixner W, Dokholyan NV, Diatchenko L.
Mol Pain 8:25. doi: 10.1186/1744-8069-8-25. 2012
4COMT
Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X, Peng Q, Qin A, Chen Z, Lin L, Deng Y, Xie L, Xu J, Li H, Li T, Li S, Zhao J.
Diagn Pathol 7:136. doi: 10.1186/1746-1596-7-136. 2012
5APOE, COMT
Role of the apolipoprotein E and catechol-O-methyltransferase genes in prospective and retrospective memory traits.
Dongés B, Haupt LM, Lea RA, Chan RC, Shum DH, Griffiths LR.
Gene 506(1):135-40. doi: 10.1016/j.gene.2012.06.067. Epub 2012 Jul 3. 2012
6COMT
COMT as a drug target for cognitive functions and dysfunctions.
Scheggia D, Sannino S, Scattoni ML, Papaleo F.
CNS Neurol Disord Drug Targets 11(3):209-21. Review. 2012
7COMT
COMT val158met polymorphism and neural pain processing.
Schmahl C, Ludäscher P, Greffrath W, Kraus A, Valerius G, Schulze TG, Treutlein J, Rietschel M, Smolka MN, Bohus M.
PLoS One 7(1):e23658. doi: 10.1371/journal.pone.0023658. Epub 2012 Jan 11. 2012
8COMT
Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development.
Chen J, Song J, Yuan P, Tian Q, Ji Y, Ren-Patterson R, Liu G, Sei Y, Weinberger DR.
J Biol Chem 286(40):34752-60. doi: 10.1074/jbc.M111.262790. Epub 2011 Aug 16. 2011
9COMT
Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice.
Myöhänen TT, Schendzielorz N, Männistö PT.
J Neurochem 113(6):1632-43. doi: 10.1111/j.1471-4159.2010.06723.x. Epub 2010 Mar 31. 2010
10COMT, SLC6A3
Variation in dopamine genes influences responsivity of the human reward system.
Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF.
Proc Natl Acad Sci U S A 106(2):617-22. Epub 2008 Dec 22. 2009
11COMT, TPMT
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.
Ross CJ, Katzov-Eckert H, Dubé MP, Brooks B, Rassekh SR, Barhdadi A, Feroz-Zada Y, Visscher H, Brown AM, Rieder MJ, Rogers PC, Phillips MS, Carleton BC, Hayden MR; CPNDS Consortium.
Nat Genet 41(12):1345-9. Epub 2009 Nov 8.PMID: 19898482 2009
12DEL22q11, COMT, SCZD4
Schizophrenia and 22q11.2 deletion syndrome.
Bassett AS, Chow EW.
Curr Psychiatry Rep 10(2):148-57. 2008
13PRODH, COMT
PRODH gene is associated with executive function in schizophrenic families.
Li T, Ma X, Hu X, Wang Y, Yan C, Meng H, Liu X, Toulopoulou T, Murray RM, Collier DA.
Am J Med Genet B Neuropsychiatr Genet 147B(5):654-7. 2008
14CHGB, COMT, CSF2RA, DAO, DAOA, DRD3, DTNBP1, HTR2A, PIP4K2A, RGS4, SCZD3
Candidate genes for schizophrenia: a survey of association studies and gene ranking.
Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z.
Am J Med Genet B Neuropsychiatr Genet 147B(7):1173-81. 2008
15APOE, COMT, DAO, DRD1, DRD2, DRD4, DTNBP1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SCZD23, SLC6A4, TP53, TPH1
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.
Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L.
Nat Genet 40(7):827-34. 2008
16ARVCF, COMT, GNB1L, PRODH
Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE, Howley S, Murphy KC.
Dev Disabil Res Rev 14(1):26-34. Review. 2008
17COMT
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.
Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R.
Nature 453(7198):1117-21. doi: 10.1038/nature06951. Epub 2008 May 11. 2008
18DEL22Q11, PRODH, HPI, VCF, COMT
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
Raux G, Bumsel E, Hecketsweiler B, van Amelsvoort T, Zinkstok J, Manouvrier-Hanu S, Fantini C, Breviere GM, Di Rosa G, Pustorino G, Vogels A, Swillen A, Legallic S, Bou J, Opolczynski G, Drouin-Garraud V, Lemarchand M, Philip N, Gerard-Desplanches A, Carlier M, Philippe A, Nolen MC, Heron D, Sarda P, Lacombe D, Coizet C, Alembik Y, Layet V, Afenjar A, Hannequin D, Demily C, Petit M, Thibaut F, Frebourg T, Campion D.
Hum Mol Genet 16(1):83-91. Epub 2006 Nov 29. 2007
19COMT
Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P, Hayes RB, Chanock SJ, Caporaso NE.
Hum Genet 122(1):41-9. Epub 2007 May 12. 2007
20ADHD, COMT, DRD4, SLC6A3
An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD.
Boonstra AM, Kooij JJ, Buitelaar JK, Oosterlaan J, Sergeant JA, Heister JG, Franke B.
Am J Med Genet B Neuropsychiatr Genet [Epub ahead of print] 2007
21COMT, GRIN2A
Molecular mechanisms of schizophrenia.
Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J.
Cell Physiol Biochem 20(6):687-702. Review. 2007
22COMT, DEL22Q11, SCZD4
Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL.
Am J Psychiatry 164(4):663-9. 2007
23DAOA, PRODH, DTNBP1, NRG1, DISC1, NOS1Ap, ZDHHC8, CLINT1, TAAR6, COMT, GABRA1, GABRP, HPI
Schizophrenia genetics: uncovering positional candidate genes.
Karayiorgou M, Gogos JA.
Eur J Hum Genet 14(5):512-9. 2006
24DTNBP1, NRG1, TAAR6, DTNBP1, COMT, RGS4, PPP3CC, ZDHHC8, AKT1, DAOA, G30
Molecular genetic studies of schizophrenia.
Riley B, Kendler KS.
Eur J Hum Genet 14(6):669-80. 2006
25COMT
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.
Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S.
Hum Mol Genet 15(21):3132-45. Epub 2006 Sep 19. 2006
26COMT, DAOA, DISC1
Neurobiology of schizophrenia.
Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT.
Neuron 52(1):139-53. Review. 2006
27COMT, DAO, DAOA, DISC1, DTNBP1, HPI, MAFD13, MAFD17, NRG1, P2RX7, PPP3CC, PRODH, RGS4, SCZD23, TAAR6, ZDHHC8
The genetics of schizophrenia and bipolar disorder: dissecting psychosis.
Craddock N, O'donovan MC, Owen MJ.
J Med Genet 42(3):193-204. 2005
28FAM58B, VCF, HPI, COMT, PRODH
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW, Huang A, Tsao MS, Gallie BL.
Oncogene 24(30):4741-53. 2005
29COMT, HT2A, DRD2, DRD4, SLC6A3
Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope.
Abdolmaleky HM, Thiagalingam S, Wilcox M.
Am J Pharmacogenomics 5(3):149-60. Review. 2005
30COMT, DEL22Q11
COMT: a common susceptibility gene in bipolar disorder and schizophrenia.
Shifman S, Bronstein M, Sternfeld M, Pisante A, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Yakir B, Zak NB, Darvasi A.
Am J Med Genet 128B(1):61-4. 2004
31COMT, DEL22Q11
Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome.
Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ.
Am J Psychiatry 161(9):1700-2. 2004
32COMT
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor
Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D.
Science 299(5610):1240-3. 2003
33COMT, DGCR6, HIRA, SEPTIN5, TSSK1A, TSSK2, ZNF74
A comprehensive analysis of 22q11 gene expression in the developing and adult brain.
Maynard TM, Haskell GT, Peters AZ, Sikich L, Lieberman JA, LaMantia AS.
Proc Natl Acad Sci U S A 100(24):14433-8. Epub 2003 Nov 12. 2003
34COMT
A highly significant association between a COMT haplotype and schizophrenia.
Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A.
Am J Hum Genet 71(6):1296-302. 2002
35COMT
No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample.
Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M.
Am J Med Genet 96(3):282-4. 2000
36COMT
No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.
Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ.
Am J Med Genet 96(3):285-8. 2000
37COMT
Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with adhd impulsive-hyperactive phenotype.
Eisenberg J, et al.
Am J Med Genet 88(5):497-502 1999
38COMT
Linkage disequilibrium on the COMT gene in French schizophrenics and controls.
de Chaldee M, et al.
Am J Med Genet 88(5):452-457 1999
39COMT
Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity.
Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, Nemanov L, Ebstein RP.
Am J Med Genet 88(6):628-33 1999
40CACNB1, COMT, PPP2R5B, SATB1, SRP14, XRCC4
Identification and chromosomal localization of human genes containing CAG/CTG repeats expressed in testis and brain.
Bulle F, Chiannilkulchai N, Pawlak A, Weissenbach J, Gyapay G, Guellaen G.
Genome Res 7(7):705-15. 1997
41COMT
Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.
Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I.
Eur J Biochem 223(3):1049-59. 1994
42COMT
The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI.
Winqvist R, et al.
Cytogenet Cell Genet 59 : 253-257. 1992
43COMT
Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2.
Grossman MH, et al.
Genomics 12 : 822-825. 1992
44COMT
The gene for human catechol-O-methyltransferase (COMT) maps to 22pter-22q11.1.
Grossman MH, et al.
(HGM11) Cytogenet Cell Genet 58 : 2048. 1991
45COMT
The increased COMT activity in Down Syndrome patients is not a consequence of dosage effect owing to location of the gene on chromosome 21 : further evidence.
Brahe C, et al.
Am J Med Genet 24 : 203-204. 1986
46COMT
Assignment of the catechol-O-methyltransferase gene to human chromosome 22 in somatic cell hybrids.
Brahe C, et al.
Hum Genet 74 : 230-234. 1986
47COMT
370.
Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development.
Chen J, Song J, Yuan P, Tian Q, Ji Y, Ren-Patterson R, Liu G, Sei Y, Weinberger DR hen J, Song J, Yuan P, Tian Q, Ji Y, Ren-Patterson R, Liu G, Sei Y, Weinberger DR.
48COMT
430.
Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression.
Palmer K, Saglam B, Whitehead C, Stock O, Lappas M, Tong S almer K, Saglam B, Whitehead C, Stock O, Lappas M, Tong S.